跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,184 条关于
“KRAS-mutated cholangiocarcinoma”
全部
4,184
临床试验
2,646
药物
260
机构
1
资讯
1,277
9个月前
GENFIT's GNS561 Combination Therapy Shows Disease Stabilization in Advanced Cholangiocarcinoma Patients
去年
GENFIT Highlights Progress in PBC and ACLF Programs at The Liver Meeting 2024
去年
GENFIT to Initiate New ACLF Clinical Trials and Awaits Key Data Readouts in 2025
3个月前
GENFIT Reports Strong Q1 2026 Revenue Growth Driven by Iqirvo Royalties, Advances Pipeline Across Liver Disease Portfolio
去年
Real-World Data Confirm Ivosidenib Efficacy in IDH1-Mutated Cholangiocarcinoma
4年前
FDA Approves Sotorasib for KRAS G12C Mutated Metastatic NSCLC
去年
FDA Approves Sotorasib Plus Panitumumab for KRAS G12C-Mutated Metastatic Colorectal Cancer
去年
Daraxonrasib and Zoldonrasib Show Promise in RAS-Mutated Pancreatic Cancer
去年
Novel Drug Combination Shows Promise Against KRAS-Mutated Lung Cancer Resistance
去年
Bayer Initiates Phase I Trial of SOS1 Inhibitor BAY3498264 for Advanced KRAS-Mutated Tumors
第 1 页，共 128 页
上一页
下一页
